Skip to main content
Livermore
Livermore
ZHEN

Carolina Wealth Advisors, LLC

SEC CIK
0001786411
Latest filing
Jul 9, 2026

The latest 13F from Carolina Wealth Advisors, LLC covers Q2 2026 (filed Jul 9, 2026): 278 long positions worth $255.1M. The top 10 holdings make up 38.8% of the portfolio, and the largest is Schwab Strategic Tr at 7.1%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
20
Est. +$647.4K
Added
59
Est. +$15.0M
Reduced
73
Est. −$14.8M
Sold out
20
Est. −$659.7K

Top 5 holdings

Share of this quarter's portfolio value

  1. Schwab Strategic Tr808524680
    7.1%$18.1M
  2. BNY Mellon ETF Trust09661T107
    6.6%$16.9M
  3. BNY Mellon ETF Trust09661T602
    5.0%$12.9M
  4. Schwab US Tips ETF808524870
    4.9%$12.5M
  5. SPDR Series Trust78468R606
    3.9%$9.90M

Share of portfolio

Top 5 holdings and the other 273 positions, by share of portfolio value

  1. Schwab Strategic Tr7.1%
  2. BNY Mellon ETF Trust6.6%
  3. BNY Mellon ETF Trust5.0%
  4. Schwab US Tips ETF4.9%
  5. SPDR Series Trust3.9%
  6. Other 273 positions72.4%

Biggest buys

New and added positions, by estimated amount bought

  1. SNDKSandisk Corp
    +$3.00MAddedHistory
  2. FROFrontline plc
    +$2.74MAddedHistory
  3. ABBVAbbVie Inc.
    +$1.92MAddedHistory
  4. MUMicron Technology Inc
    +$1.92MAddedHistory
  5. TXNTexas Instruments Inc
    +$1.89MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. SNDKSandisk Corp
    +1.19 pp<0.1% → 1.2%History
  2. TXNTexas Instruments Inc
    +1.14 pp0.9% → 2.0%History
  3. FROFrontline plc
    +1.07 pp0.1% → 1.2%History
  4. ABBVAbbVie Inc.
    +0.84 pp1.0% → 1.8%History
  5. BNY Mellon ETF Trust09661T107
    +0.79 pp5.9% → 6.6%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. GILDGilead Sciences, Inc.
    −$4.50MReducedHistory
  2. MRKMerck & Co., Inc.
    −$2.05MReducedHistory
  3. CORCencora, Inc.
    −$1.47MReducedHistory
  4. PLTRPalantir Technologies Inc.
    −$1.45MReducedHistory
  5. LRCXLam Research Corp
    −$1.14MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. GILDGilead Sciences, Inc.
    −2.07 pp2.1% → <0.1%History
  2. MRKMerck & Co., Inc.
    −0.79 pp2.4% → 1.6%History
  3. PLTRPalantir Technologies Inc.
    −0.76 pp0.8% → <0.1%History
  4. CORCencora, Inc.
    −0.68 pp0.7% → <0.1%History
  5. BPBP PLC
    −0.42 pp1.6% → 1.1%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$255.1M
+$15.0M (+6.2%) vs. prior quarter
Positions
278
0 vs. prior quarter
Top 10 concentration
38.8%
Top 10 as share of value
Turnover
6.2%
Q2 2026, one quarter
Average holding period
9.4 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $255.1M (Q2 2026)

Q1 2021: $137.1MQ2 2021: $148.4MQ3 2021: $151.0MQ4 2021: $177.0MQ1 2022: $158.3MQ2 2022: $151.4MQ3 2022: $127.4MQ4 2022: $158.8MQ1 2023: $170.8MQ2 2023: $166.2MQ3 2023: $177.1MQ4 2023: $193.0MQ1 2024: $184.5MQ2 2024: $203.9MQ3 2024: $196.6MQ4 2024: $185.8MQ1 2025: $185.4MQ2 2025: $202.7MQ3 2025: $231.5MQ4 2025: $224.3MQ1 2026: $240.1MQ2 2026: $255.1M
Q1 2021Q2 2026
13F filings of Carolina Wealth Advisors, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 9, 2026278$255.1MSchwab Strategic TrBNY Mellon ETF TrustBNY Mellon ETF Trustvs. Q1 2026SEC
Q1 2026Apr 7, 2026278$240.1MSchwab Strategic TrBNY Mellon ETF TrustBNY Mellon ETF Trustvs. Q4 2025SEC
Q4 2025Jan 21, 2026272$224.3MSchwab Strategic TrBNY Mellon ETF TrustSchwab US Tips ETFvs. Q3 2025SEC
Q3 2025Oct 7, 2025232$231.5MSchwab Strategic TrBNY Mellon ETF TrustSchwab US Tips ETFvs. Q2 2025SEC
Q2 2025Jul 22, 2025270$202.7MVanguard BD Index FDSSchwab US Tips ETFMOSvs. Q1 2025SEC
Q1 2025Apr 24, 2025284$185.4MVanguard BD Index FDSSchwab US Tips ETFABBVvs. Q4 2024SEC
Q4 2024Jan 14, 2025298$185.8MVanguard BD Index FDSSchwab US Tips ETFDKSvs. Q3 2024SEC
Q3 2024Oct 21, 2024339$196.6MVanguard BD Index FDSSchwab US Tips ETFRDNvs. Q2 2024SEC
Q2 2024Jul 12, 2024226$203.9MVanguard BD Index FDSSchwab US Tips ETFAVGOvs. Q1 2024SEC
Q1 2024Apr 5, 2024222$184.5MVanguard BD Index FDSSchwab US Tips ETFAVGOvs. Q4 2023SEC
Q4 2023Jan 23, 2024247$193.0MVanguard BD Index FDSSchwab US Tips ETFWSMvs. Q3 2023SEC
Q3 2023Oct 17, 2023266$177.1MVanguard BD Index FDSSchwab US Tips ETFWSMvs. Q2 2023SEC
Q2 2023Jul 17, 2023255$166.2MVanguard BD Index FDSSchwab US Tips ETFAVGOvs. Q1 2023SEC
Q1 2023Apr 14, 2023275$170.8MVanguard BD Index FDSSchwab US Tips ETFABBVvs. Q4 2022SEC
Q4 2022Jan 10, 2023248$158.8MVanguard BD Index FDSSchwab US Tips ETFBKEvs. Q3 2022SEC
Q3 2022Oct 14, 2022260$127.4MSchwab US Tips ETFiShares TrABBVvs. Q2 2022SEC
Q2 2022Jul 19, 2022284$151.4MSchwab US Tips ETFiShares TrABBVvs. Q1 2022SEC
Q1 2022Apr 18, 2022290$158.3MSchwab US Tips ETFiShares TrAVGOvs. Q4 2021SEC
Q4 2021Jan 24, 2022285$177.0MSchwab US Tips ETFAVGOINFYvs. Q3 2021SEC
Q3 2021Oct 22, 2021278$151.0MSchwab US Tips ETFINFYAVGOvs. Q2 2021SEC
Q2 2021Jul 22, 2021295$148.4MSchwab US Tips ETFAVGOINFYvs. Q1 2021SEC
Q1 2021Apr 9, 2021313$137.1MSchwab US Tips ETFAVGOINFY–SEC